-+ 0.00%
-+ 0.00%
-+ 0.00%
BriaCell signs manufacturing deal with FUJIFILM Biotechnologies for Bria-IMT Phase 3 supply
Share
Listen to the news
BriaCell signs manufacturing deal with FUJIFILM Biotechnologies for Bria-IMT Phase 3 supply
  • Briacell Therapeutics signed a manufacturing arrangement with FUJIFILM Biotechnologies California to supply Bria-IMT for its pivotal Phase 3 study.
  • Deal secures capacity for the remainder of the Phase 3 program, targeting commercial-scale manufacturing if Bria-IMT advances.
  • Bria-IMT is being tested with an immune checkpoint inhibitor in metastatic breast cancer.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Briacell Therapeutics Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607150730PRIMZONEFULLFEED9762109) on July 15, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending